Hospitalised COVID-19 Patients Cohort Study in the EuCARE Project

NCT05463380 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 22000

Last updated 2024-08-29

No results posted yet for this study

Summary

The WP3 hospitalized cohort in EuCARE is an observational multicentre study including collection of retrospective (historical) and prospective data from hospitalized COVID-19 patients followed at 12 clinics from 11 countries from 4 continents. In a subset of patients, peripheral blood, viral isolates and/or viral sequences are collected for analysis in WP2 with regards to neutralising antibodies, cellular immunity and SARS-CoV-2 diagnostics. Data and results from analysis of biological material will be analysed by biostatistical methods and with artificial intelligence in WP5. This analysis will focus on the impact on clinical outcome of viral variants / viral sequences as well as the vaccines used and the vaccination schedules.

Conditions

Interventions

OTHER

standard of care

The patient will be treated following the satndard of care in the participating units

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER
  • Centro Hospitalar Lisboa Ocidental

    collaborator OTHER_GOV
  • Heinrich-Heine University, Duesseldorf

    collaborator OTHER
  • ASST Santi Paolo e Carlo

    collaborator OTHER
  • Imperial College London

    collaborator OTHER
  • Vilnius University Hospital Santaros Klinikos

    collaborator OTHER
  • University of Rome Tor Vergata

    collaborator OTHER
  • Bach Mai Hospital

    collaborator OTHER
  • Kenya Medical Research Institute

    collaborator OTHER
  • Hospital Regional de Alta Especialidad "Dr. Juan Graham Casasus"

    collaborator OTHER
  • University Hospitals Dorset NHS Foundation Trust

    collaborator OTHER_GOV
  • Euresist Network GEIE

    lead OTHER

Principal Investigators

  • ANDERS Sönnerborg, Prof · Karolinska Institutet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-23
Primary Completion
2026-10-13
Completion
2026-10-13

Countries

  • Germany
  • Italy
  • Kenya
  • Lithuania
  • Mexico
  • Portugal
  • Sweden
  • United Kingdom
  • Vietnam

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05463380 on ClinicalTrials.gov